Scienture Holdings, Inc.
SCNX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.02 | -0.00 | 0.03 | -0.01 |
| FCF Yield | -69.86% | -38.88% | -36.98% | -63.72% |
| EV / EBITDA | -1.36 | -1.99 | -2.52 | -0.42 |
| Quality | ||||
| ROIC | -14.32% | -58.31% | -151.34% | -105.45% |
| Gross Margin | 4.39% | 3.60% | 53.85% | 47.99% |
| Cash Conversion Ratio | 0.78 | 0.26 | 0.65 | 0.48 |
| Growth | ||||
| Revenue 3-Year CAGR | -76.29% | -48.34% | -15.72% | 9.97% |
| Free Cash Flow Growth | -541.08% | -42.21% | 39.56% | -14.94% |
| Safety | ||||
| Net Debt / EBITDA | -0.19 | -1.08 | -0.26 | 0.36 |
| Interest Coverage | -11.01 | -3.85 | -8.67 | -224.34 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 1,358.26 | 72.20 | 91.39 |
| Cash Conversion Cycle | 6,458.81 | 269.81 | -13.25 | 6.27 |